IGC Pharma Expands Phase 2 CALMA Trial into Colombia's Premier Alzheimer's Research Center

IGC Pharma Expands Phase 2 CALMA Trial into Colombia's Premier Alzheimer's Research Center  The Globe and Mail


1 M.
Science
ID: -2487511709318981405


Similar News expand_more


Science
Science
Technology
Economics
Crime
Economics
Economics
Crime
Economics
Economics
Economics
Economics
Crime
Economics
Economics
Economics
Crime
Economics
Crime
Economics
Economics
Education
Economics
Entertainment
Economics
Weather
Politics
Politics
Politics
Politics
Economics
Economics
Travel
Crime
Travel
Crime
Economics
Weather
Crime
Crime
Technology
Economics
Crime
Economics
Politics
Economics
Economics
Politics
Economics
Popular countries based on strong economic and political relations

Add Watch Country

arrow_drop_down